A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease

Clinical trial NCT01422187 · COMPLETED

Trial details

NCT number: NCT01422187
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2011-08-01
Primary completion: 2014-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.